The big biotech, which has made genetic medicine a focus in recent years, is paying Tessera $150 million for rights to a ...

Indiana shows high potential for the state to become the premiere destination to research, commercialize, scale biotechnology ...

The results position Belite, one of the sector’s top-performing companies since 2022, to seek approval of what could be the ...

A deal announced Monday will see the U.K. temporarily sidestep levies on Britain-originated drugs by loosening rules that ...

The startup’s lead prospect stabilizes abnormal proteins in patients with amyloid “light chain” amyloidosis, an approach that ...